ISSN: 1837-9664Journal of Cancer
Global reach, higher impact
J Cancer 2016; 7(7):854-861. doi:10.7150/jca.14777 This issue Cite
Research Paper
Effect of Comorbidity on Postoperative Survival Outcomes in Patients with Solid Cancers: A 6-Year Multicenter Study in Taiwan
1. Department of Medical Oncology, Chang Gung Memorial Hospital, Linkou, Taiwan;
2. Graduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine, Taiwan;
3. Department of Medical Oncology, Chang Gung Memorial Hospital, Chiayi, Taiwan;
4. Department of Medical Oncology, Chang Gung Memorial Hospital, Keelung, Taiwan;
5. Department of Surgery, Chang Gung Memorial Hospital, Linkou, Taiwan;
6. Department of Medical Oncology, Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Citation:
Chou WC, Chang PH, Lu CH, Liu KH, Hung YS, Hung CY, Liu CT, Yeh KY, Lin YC, Yeh TS. Effect of Comorbidity on Postoperative Survival Outcomes in Patients with Solid Cancers: A 6-Year Multicenter Study in Taiwan. J Cancer 2016; 7(7):854-861. doi:10.7150/jca.14777. https://www.jcancer.org/v07p0854.htm
Other stylesAbstract
Purpose: Patients with comorbidities are more likely to experience treatment-related toxicities and death. Our aim was to examine the effect of comorbidity on postoperative survival outcomes in patients with solid cancers.
Methods: In total, 37,288 patients who underwent potentially curative operations for solid cancers at four affiliated hospitals of the Chang Gung Memorial Hospital, between 2007 and 2012, were stratified according to the Charlson Comorbidity Index (CCI) for postoperative survival analysis. Multivariate Cox regression was used to adjust hazard ratios of survival outcomes among different CCI subgroups.
Results: A significantly greater proportion of patients with comorbidities presented with poorer clinicopathological characteristics compared to those without. After cancer surgery, 26% of patients died after a median follow-up duration of 38.9 months. Overall mortality rates of patients with CCI scores of 0, 1, 2, 3, 4, and 5-8 were 22.9%, 29.5%, 38.2%, 43.2%, 50.2%, and 56.4%, respectively. After adjusting for other clinicopathological factors, patients with increasing CCI scores were associated with significantly reduced overall and noncancer-specific survival rates, while only patients with CCI scores of >2 were associated with higher cancer-specific mortality rates.
Conclusions: Patients with increasing numbers of comorbidities were associated with reduced postoperative survival outcomes. Patients with multiple comorbidities were most vulnerable to both cancer- and noncancer-specific deaths in the first 6 months after cancer surgery. Our results suggest that for both the patient and clinician, it should be taken into consideration about cancer surgery when dealing with multiple comorbidities.
Keywords: comorbidity, Charlson Comorbidity Index, postoperative mortality, cancer surger.
Citation styles
APA
Chou, W.C., Chang, P.H., Lu, C.H., Liu, K.H., Hung, Y.S., Hung, C.Y., Liu, C.T., Yeh, K.Y., Lin, Y.C., Yeh, T.S. (2016). Effect of Comorbidity on Postoperative Survival Outcomes in Patients with Solid Cancers: A 6-Year Multicenter Study in Taiwan. Journal of Cancer, 7(7), 854-861. https://doi.org/10.7150/jca.14777.
ACS
Chou, W.C.; Chang, P.H.; Lu, C.H.; Liu, K.H.; Hung, Y.S.; Hung, C.Y.; Liu, C.T.; Yeh, K.Y.; Lin, Y.C.; Yeh, T.S. Effect of Comorbidity on Postoperative Survival Outcomes in Patients with Solid Cancers: A 6-Year Multicenter Study in Taiwan. J. Cancer 2016, 7 (7), 854-861. DOI: 10.7150/jca.14777.
NLM
Chou WC, Chang PH, Lu CH, Liu KH, Hung YS, Hung CY, Liu CT, Yeh KY, Lin YC, Yeh TS. Effect of Comorbidity on Postoperative Survival Outcomes in Patients with Solid Cancers: A 6-Year Multicenter Study in Taiwan. J Cancer 2016; 7(7):854-861. doi:10.7150/jca.14777. https://www.jcancer.org/v07p0854.htm
CSE
Chou WC, Chang PH, Lu CH, Liu KH, Hung YS, Hung CY, Liu CT, Yeh KY, Lin YC, Yeh TS. 2016. Effect of Comorbidity on Postoperative Survival Outcomes in Patients with Solid Cancers: A 6-Year Multicenter Study in Taiwan. J Cancer. 7(7):854-861.
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.